Theratechnologies (NASDAQ:THTX) Stock Price Down 0.6% – Time to Sell?

Theratechnologies Inc. (NASDAQ:THTX)’s share price traded down 0.6% during mid-day trading on Friday . The company traded as low as $1.69 and last traded at $1.72. 84,056 shares were traded during mid-day trading, a decline of 45% from the average session volume of 153,814 shares. The stock had previously closed at $1.73.

Theratechnologies Trading Down 0.6 %

The firm’s fifty day moving average is $1.54 and its 200 day moving average is $1.40. The company has a market cap of $79.09 million, a PE ratio of -17.20 and a beta of 1.30.

Institutional Trading of Theratechnologies

A hedge fund recently raised its stake in Theratechnologies stock. Cyndeo Wealth Partners LLC raised its position in Theratechnologies Inc. (NASDAQ:THTX) by 26.1% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 131,311 shares of the company’s stock after buying an additional 27,191 shares during the period. Cyndeo Wealth Partners LLC owned about 0.29% of Theratechnologies worth $163,000 at the end of the most recent reporting period.

About Theratechnologies

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.